Feb
01
Medivice angages Bielderman CRO for their New Colon Cancer Device
Medivice engages Bielderman CRO for their new device against colon cancer. The study will be started in 8 Countries with a total of 210 patients. The device is based on a High Tech technology and delivers a quick access to the polyp. More information will follow soon.
.